NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

Other illness

• Have medical conditions that significantly impact digestion, metabolism, or food intake (e.g., surgical loss of esophagus, stomach, or colon; pancreas dysfunction; brain surgery that alters cognition; severe food allergies; etc.) or have active metabolic or digestive illnesses (i.e., Celiac disease, IBS, renal insufficiency, hepatic insufficiency).

Other

• Cognitively unable to consent or have physical or mental limitations that would prevent full participation in the program.
• Pregnant or planning to become pregnant during the study.
• Unable to receive medically-tailored meals for the course of the study if being assigned to the intervention arm, including lack of a permanent address to which meals can be delivered (a friend or home address is acceptable given it is used on a consistent basis), not having a fully functioning kitchen with a microwave or oven for cooking, not having a standard-sized refrigerator with a freezer with storage capacity to hold one week's worth of meals; or unwilling to sign the MTM agreement.

• Adults (18+ years of age)
• Newly diagnosed patients with lung cancer (non-small cell and small cell lung cancer):
  • Patients with stages I-III lung cancer:
  • 1\) starting multimodality therapy including chemoradiation (either concurrent or sequential), systemic treatment, or radiation alone; and may be followed by surgery; or 2) starting adjuvant therapy after lung resection ((chemotherapy alone, radiation alone, or chemoradiation (either concurrent or sequential))
  • Patients with stage IV lung cancer or recurrent/metastatic:
  • Eligible at diagnosis and for up to 3 months after starting treatment
  • o Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-3
• Vulnerable patients who meet at least one of the following criteria:
  • Economically disadvantaged (household gross monthly income at or below 130% of the Federal Poverty Level)
  • Racial and ethnic minorities (African Americans, American Indians and Alaska Natives, Asians and Pacific Islanders, and Hispanics)
  • No health insurance
  • Elderly patients (ages 65 years or older)
  • Reside in rural areas (non-metropolitan counties with less than 50,000 people)
• Voluntarily provide consent, HIPPA authorization form, and consent from treating oncologist.
• Able to speak and read English themselves or with minimal help.
• Able to receive medically-tailored meals for the course of the study if being assigned to the intervention arm, and willing to sign the MTM agreement.